In Vitro and In Vivo Models for Analysis of Resistance to Anticancer Molecular Therapies

The efficacy of classical and molecular therapies in cancer is hampered by the occurrence of primary (intrinsic) and secondary (acquired) refractoriness of tumours to selected therapeutic regimens. Nevertheless, the increased knowledge of the genetic, molecular and metabolic mechanisms underlying ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosa, Roberta, Monteleone, Francesca, Zambrano, Nicola, Bianco, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082167/
https://www.ncbi.nlm.nih.gov/pubmed/23992330
http://dx.doi.org/10.2174/09298673113209990226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082167/
https://www.ncbi.nlm.nih.gov/pubmed/23992330
http://dx.doi.org/10.2174/09298673113209990226

Ejemplares similares